ROCKVILLE, Md. , June 9, 2021 /PRNewswire/ -- REGENXBIO Inc. (Nasdaq: RGNX) today announced it will participate in the following June investor conferences, which will each be held in a virtual meeting format:
Bank of America 2021 Napa Biopharma Virtual Conference
Fireside Chat: Wednesday, June 16, 2021 at 12:30 p.m. E.T.
Raymond James Human Health Innovation Conference
Date: Monday, June 21, 2021
A live webcast of the Bank of America fireside chat can be accessed in the 'Investors' section of REGENXBIO's website at www.regenxbio.com . An archived replay of the webcast will be available on the same website for approximately 30 days following the fireside chat.
About REGENXBIO Inc.
REGENXBIO is a leading clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. REGENXBIO's NAV ® Technology Platform, a proprietary adeno-associated virus (AAV) gene delivery platform, consists of exclusive rights to more than 100 novel AAV vectors, including AAV7, AAV8, AAV9 and AAVrh10. REGENXBIO and its third-party NAV Technology Platform Licensees are applying the NAV Technology Platform in the development of a broad pipeline of candidates in multiple therapeutic areas.
Contacts:
Tricia Truehart
Investor Relations and Corporate Communications
347-926-7709
ttruehart@regenxbio.com
Investors:
Brendan Burns , 212-600-1902
brendan@argotpartners.com
Media:
David Rosen , 212-600-1902
david.rosen@argotpartners.com
View original content to download multimedia: http://www.prnewswire.com/news-releases/regenxbio-to-participate-in-upcoming-investor-conferences-301308489.html
SOURCE REGENXBIO Inc.
